Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Oiva Health Danmark ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   1.9% 1.7% 1.7% 2.2% 1.2% 1.2% 20.5% 20.3%   Credit score (0-100)   72 72 71 66 80 81 5 5   Credit rating   A A A BBB A A B B   Credit limit (kDKK)   2.0 6.3 7.5 0.4 373.4 370.6 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   4,470 4,118 5,463 4,866 10,877 10,798 0.0 0.0   EBITDA   2,479 2,116 3,076 2,097 7,037 6,029 0.0 0.0   EBIT   1,611 778 1,514 160 4,714 3,296 0.0 0.0   Pre-tax profit (PTP)   1,598.4 740.1 1,498.8 119.7 4,637.7 3,253.1 0.0 0.0   Net earnings   1,245.2 724.1 1,417.8 81.7 3,616.2 2,389.1 0.0 0.0   Pre-tax profit without non-rec. items   1,598 740 1,499 120 4,638 3,253 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   22.9 14.6 6.3 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   5,975 6,699 8,117 8,199 11,815 14,204 -1,761 -1,761   Interest-bearing liabilities   1,986 1,782 188 2,003 1,089 274 1,761 1,761   Balance sheet total (assets)   14,418 15,682 18,839 19,774 22,153 26,091 0.0 0.0   Net Debt   1,985 1,760 173 1,980 826 -3,003 1,761 1,761     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   4,470 4,118 5,463 4,866 10,877 10,798 0.0 0.0   Gross profit growth   6.3% -7.9% 32.7% -10.9% 123.5% -0.7% -100.0% 0.0%   Employees   4 4 5 5 6 7 0 0   Employee growth %   -20.0% 0.0% 25.0% 0.0% 20.0% 16.7% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   14,418 15,682 18,839 19,774 22,153 26,091 0 0   Balance sheet change%   29.7% 8.8% 20.1% 5.0% 12.0% 17.8% -100.0% 0.0%   Added value   2,479.1 2,115.6 3,075.8 2,097.5 6,651.5 6,028.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   3,114 -437 653 46 -554 -1,176 -20,353 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   36.0% 18.9% 27.7% 3.3% 43.3% 30.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   12.6% 5.2% 8.8% 0.9% 22.5% 13.7% 0.0% 0.0%   ROI %   18.8% 7.1% 13.4% 1.4% 31.8% 18.5% 0.0% 0.0%   ROE %   23.3% 11.4% 19.1% 1.0% 36.1% 18.4% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   41.4% 42.7% 43.1% 41.5% 53.3% 54.4% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   80.1% 83.2% 5.6% 94.4% 11.7% -49.8% 0.0% 0.0%   Gearing %   33.2% 26.6% 2.3% 24.4% 9.2% 1.9% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   1.3% 2.0% 1.5% 4.4% 5.2% 6.3% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   0.4 0.5 0.5 0.3 0.6 0.8 0.0 0.0   Current Ratio   0.4 0.5 0.5 0.3 0.6 0.8 0.0 0.0   Cash and cash equivalent   1.3 21.6 14.2 23.2 263.8 3,277.7 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -3,261.7 -3,345.2 -3,942.6 -5,920.1 -2,055.9 -1,541.2 -880.6 -880.6   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   620 529 615 419 1,109 861 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   620 529 615 419 1,173 861 0 0   EBIT / employee   403 194 303 32 786 471 0 0   Net earnings / employee   311 181 284 16 603 341 0 0